PCI-registry-based trial shows that IFR is non-inferior to FFR, with reduced discomfort and stenting3' education - Mar. 20, 2017 - Matthias Götberg - Lund University, Sweden
ACC 2017 Matthias Götberg summarises the advantages of the registry-based trial design of the randomised IFR-SWEDEHEART trial and shares the results of this study into clinical outcomes after IFR as compared with FFR.
This video was recorded during ACC 2017, March 17-19 in Washington, DC, USA. PACE-cme did not receive financial support for the production of this video.
The educational content reflects the personal opinion of the expert.
Matthias Götberg - Lund University, Lund, Sweden